280 related articles for article (PubMed ID: 4397769)
1. [Hydroxyproline excretion in urine in chronic connective tissue disease].
Emmrich R
Z Gesamte Inn Med; 1970 Dec; 25(23):1062-5. PubMed ID: 4397769
[No Abstract] [Full Text] [Related]
2. Urinary excretion of prolylhydroxyproline in rheumatic diseases.
Bienenstock HKIBRICK AC
Ann Rheum Dis; 1969 Jan; 28(1):28-30. PubMed ID: 5305862
[No Abstract] [Full Text] [Related]
3. Anti-inflammatory drugs in rheumatic diseases.
Cosh JA
Practitioner; 1974 Oct; 213(1276 SPEC NO):519-26. PubMed ID: 4376236
[No Abstract] [Full Text] [Related]
4. [Urinary hydroxyproline excretion in generalized bone diseases].
Czitober H; Raab W
Wien Z Inn Med; 1967; 48(10):401-8. PubMed ID: 5620579
[No Abstract] [Full Text] [Related]
5. [Behavior of urinary acid mucopolysaccharides in dermatological collagen diseases].
Rossi A
G Ital Dermatol Minerva Dermatol; 1969 Dec; 44(12):641-5. PubMed ID: 4243640
[No Abstract] [Full Text] [Related]
6. [Study of the secretion of 2,5 dihydroxyphenylpyruvic acid in collagen diseases].
Hladíková D; Sobĕslavský C; Susta A; Havelka S
Fysiatr Revmatol Vestn; 1968 Jul; 46(4):201-9. PubMed ID: 5691511
[No Abstract] [Full Text] [Related]
7. [Clinical significance of urinary hydroxyproline excretion].
Kreysel HW; Köhler N
Med Welt; 1973 Oct; 24(43):1654-8. PubMed ID: 4764061
[No Abstract] [Full Text] [Related]
8. [Urinary excretion of mucopolysaccharides in patients with collagen diseases (author's transl)].
Kreysel HW; Köhler A
Dermatologica; 1974; 148(1):19-27. PubMed ID: 4275497
[No Abstract] [Full Text] [Related]
9. [Collagen metabolism in combined therapy of rheumatoid arthritis].
Weimann G; Burkhardt H; Rommel K; Wepler R
Med Klin; 1973 Mar; 68(11):344-50. PubMed ID: 4348084
[No Abstract] [Full Text] [Related]
10. Effect of antiphlogistic steroids on urinary hydroxyproline excretion in systemic lupus erythematosus.
Cieślicka T
Pol Med Sci Hist Bull (1973); 1976; 15(2):235-9. PubMed ID: 959050
[TBL] [Abstract][Full Text] [Related]
11. [Chronic inflammation of the connective tissue].
Refsum SB
Tidsskr Nor Laegeforen; 1972 Apr; 92(11):791-3. PubMed ID: 4402181
[No Abstract] [Full Text] [Related]
12. [Experiences with long-term immunosuppressive therapy of connnective tissue diseases].
Apostoloff E; Reitzig P; Jendrusch C; Apostoloff G
Z Gesamte Inn Med; 1974 Jan; 29(1):26-30. PubMed ID: 4820047
[No Abstract] [Full Text] [Related]
13. [Collagen diseases within the framework of autoimmune diseases].
Fanconi G
Munch Med Wochenschr; 1966 Mar; 108(12):633-40. PubMed ID: 4383334
[No Abstract] [Full Text] [Related]
14. Fundus lesions in connective tissue disease.
Henkind P
Trans Ophthalmol Soc U K (1962); 1974 Sep; 94(3):785-806. PubMed ID: 4157047
[No Abstract] [Full Text] [Related]
15. [INCIDENCE OF THE LE PHENOMENON IN SYSTEMIC LUPUS ERYTHEMATOSUS AND OTHER COLLAGEN DISEASES BASED ON LONGITUDINAL OBSERVATIONS FOR SEVERAL YEARS].
ZITNAN D; SVEC V; NIEPEL G
Bratisl Lek Listy; 1964; 2():47-59. PubMed ID: 14167442
[No Abstract] [Full Text] [Related]
16. [Rheumatic and pararheumatic diseases. Problems of diagnosis and therapy].
Scheiffarth F
Fortschr Med; 1973 Jul; 91(20):859-62. PubMed ID: 4146346
[No Abstract] [Full Text] [Related]
17. [Current aspects of immunosuppressive therapy of collagen diseases].
Marmont A; Rossi F; Bordo D
Minerva Med; 1973 Jun; 64(46):2436-50. PubMed ID: 4723570
[No Abstract] [Full Text] [Related]
18. [The kidney in diseases of the rheumatic group].
Hallauer W; Schirmeister J; Keller P
Med Welt; 1973 Nov; 24(45):1735-7. PubMed ID: 4148966
[No Abstract] [Full Text] [Related]
19. Virologic studies in rheumatoid arthritis and other connective tissue diseases.
Phillips PE
J Exp Med; 1971 Sep; 134(3 Pt 2):313s-319s. PubMed ID: 4398320
[No Abstract] [Full Text] [Related]
20. [Anti-inflammatory agents in current therapeutics].
Leynadier F; Perrault M
Rev Prat; 1975 Jan; 25(5):365-73. PubMed ID: 170661
[No Abstract] [Full Text] [Related]
[Next] [New Search]